Literature DB >> 4811791

Prognostic factors in cryptococcal meningitis. A study in 111 cases.

R D Diamond, J E Bennett.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4811791     DOI: 10.7326/0003-4819-80-2-176

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  162 in total

1.  Efficacy of SCH39304 in murine cryptococcosis.

Authors:  B I Restrepo; J Ahrens; J R Graybill
Journal:  Antimicrob Agents Chemother       Date:  1989-08       Impact factor: 5.191

2.  Antibody response to Cryptococcus neoformans proteins in rodents and humans.

Authors:  L C Chen; D L Goldman; T L Doering; L a Pirofski; A Casadevall
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

3.  Disseminated Cryptococcus with ocular cryptococcoma in a human immunodeficiency virus-negative patient.

Authors:  Zvi A Kresch; Diego Espinosa-Heidmann; Tiffany Harper; G Jamie Miller
Journal:  Int Ophthalmol       Date:  2012-03-23       Impact factor: 2.031

4.  A 49-year-old man with aseptic meningitis and multiple cranial neuropathies.

Authors:  J C Mazziotta; H Itabashi; C Orfuss; A Charles; R Collins
Journal:  West J Med       Date:  1991-03

5.  Enhancement of nitric oxide synthesis by macrophages represents an additional mechanism of action for amphotericin B.

Authors:  N Mozaffarian; J W Berman; A Casadevall
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

6.  Prediction of unfavorable outcomes in cryptococcal meningitis: results of the multicenter Infectious Diseases International Research Initiative (ID-IRI) cryptococcal meningitis study.

Authors:  I N Hakyemez; H Erdem; G Beraud; M Lurdes; A Silva-Pinto; C Alexandru; B Bishop; F Mangani; X Argemi; M Poinot; R Hasbun; M Sunbul; M Akcaer; S Alp; T Demirdal; K Angamuthu; F Amer; E Ragab; G A Shehata; D Ozturk-Engin; N Ozgunes; L Larsen; S Zimmerli; O R Sipahi; E Tukenmez Tigen; G Celebi; N Oztoprak; A C Yardimci; Y Cag
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-12-08       Impact factor: 3.267

7.  Effects of cyclosporine in experimental cryptococcal meningitis.

Authors:  J R Perfect; D T Durack
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

8.  Immunogenic fractions of Cryptococcus neoformans.

Authors:  J R Graybill; D C Straus; T J Nealon; M Hague; R E Paque
Journal:  Mycopathologia       Date:  1982-04-23       Impact factor: 2.574

9.  Cryptococcal meningitis.

Authors:  T L Tjia; Y K Yeow; C B Tan
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-09       Impact factor: 10.154

10.  Tissue localization of Cryptococcus neoformans glucuronoxylomannan in the presence and absence of specific antibody.

Authors:  D L Goldman; S C Lee; A Casadevall
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.